UK Bans Parallel Export Of 24 Drugs As Brexit Nears
The move should help protect industry’s no-deal stockpiles
The UK government has drawn up a list of 24 medicines that must not be parallel exported to EU countries. The move is widely seen as a way of protecting stockpiles of drugs that have been built up to compensate for supply chain problems in the event of a no-deal Brexit.
You may also be interested in...
The EU association representing parallel traders says cheaper parallel imports are vital in keeping medicines affordable for member states.
There are now 31 medicines on the UK’s list of products that cannot be parallel exported to other European Economic Area countries as part of government efforts to tackle drug shortages. The parallel trade industry has attacked the initiative for lack of transparency.
The first Serious Shortage Protocol has been issued by the DHSC to tackle supply disruptions for fluoxetine capsules. The protocol came into effect on 3 October 2019 and will expire at the end of the month.